Annual Long Term Debt
$0.00
-$8.20 M-100.00%
31 December 2023
Summary:
Seelos Therapeutics annual long term debt is currently $0.00, with the most recent change of -$8.20 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$7.29 million (-100.00%). SEEL annual long term debt is now -100.00% below its all-time high of $17.89 million, reached on 31 December 2021.SEEL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
N/A
30 June 2024
Summary:
Seelos Therapeutics quarterly long term debt is not available.SEEL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -100.0% | - |
3 y3 years | -100.0% | - |
5 y5 years | - | - |
SEEL Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -100.0% | |||
5 y | 5 years | -100.0% | |||
alltime | all time | -100.0% |
Seelos Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2023 | - | $1.30 M(-55.9%) |
June 2023 | - | $2.96 M(-42.0%) |
Mar 2023 | - | $5.10 M(-37.8%) |
Dec 2022 | $8.20 M(-54.2%) | $8.20 M(-23.7%) |
Sept 2022 | - | $10.74 M(-9.1%) |
June 2022 | - | $11.81 M(-20.9%) |
Mar 2022 | - | $14.93 M(-16.6%) |
Dec 2021 | $17.89 M(+145.3%) | $17.89 M(>+9900.0%) |
June 2021 | - | $16.00 K(-99.5%) |
Mar 2021 | - | $3.27 M(-55.1%) |
Dec 2020 | $7.29 M(+57.7%) | $7.29 M(+4861.2%) |
Sept 2020 | - | $147.00 K(0.0%) |
June 2020 | - | $147.00 K(-98.0%) |
Sept 2015 | - | $7.19 M(+81.9%) |
June 2015 | - | $3.95 M(-7.9%) |
Mar 2015 | - | $4.29 M(-7.2%) |
Dec 2014 | $4.63 M(+35.5%) | $4.63 M(+319.8%) |
Sept 2013 | - | $1.10 M(+2.5%) |
June 2013 | - | $1.07 M(-68.3%) |
Mar 2013 | - | $3.39 M(-0.6%) |
Dec 2012 | $3.41 M(-16.8%) | $3.41 M(-14.7%) |
Sept 2011 | - | $4.00 M(0.0%) |
June 2011 | - | $4.00 M(-2.4%) |
Mar 2011 | - | $4.10 M(-0.0%) |
Dec 2010 | $4.10 M | $4.10 M(+0.2%) |
Sept 2010 | - | $4.09 M(-0.2%) |
June 2010 | - | $4.10 M(-0.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $4.11 M(+32.3%) |
Dec 2009 | $3.10 M(-33.8%) | $3.10 M(-13.5%) |
Sept 2009 | - | $3.59 M(-17.3%) |
June 2009 | - | $4.34 M(-7.5%) |
Mar 2009 | - | $4.69 M(0.0%) |
Dec 2008 | $4.69 M(+84.7%) | $4.69 M(-1.3%) |
Sept 2008 | - | $4.75 M(0.0%) |
June 2008 | - | $4.75 M(+81.6%) |
Mar 2008 | - | $2.62 M(+3.0%) |
Dec 2007 | $2.54 M(-15.4%) | $2.54 M(-15.4%) |
Mar 2006 | - | $3.00 M(0.0%) |
Dec 2005 | $3.00 M(-51.9%) | $3.00 M(-50.2%) |
Sept 2005 | - | $6.02 M(-0.7%) |
June 2005 | - | $6.06 M(-1.1%) |
Mar 2005 | - | $6.13 M(-1.7%) |
Dec 2004 | $6.23 M(-9.4%) | $6.23 M(-2.2%) |
Sept 2004 | - | $6.38 M(-2.3%) |
June 2004 | - | $6.53 M(-2.4%) |
Mar 2004 | - | $6.69 M(-2.7%) |
Dec 2003 | $6.88 M(+26.6%) | $6.88 M(+204.5%) |
Sept 2003 | - | $2.26 M(-28.5%) |
June 2003 | - | $3.16 M(-22.5%) |
Mar 2003 | - | $4.08 M(-24.9%) |
Dec 2002 | $5.43 M(+649.7%) | $5.43 M(+3.2%) |
Sept 2002 | - | $5.26 M(+3.6%) |
June 2002 | - | $5.08 M(+683.7%) |
Mar 2002 | - | $648.20 K(-10.5%) |
Dec 2001 | $724.60 K | $724.60 K(+19.9%) |
Sept 2001 | - | $604.10 K |
FAQ
- What is Seelos Therapeutics annual long term debt?
- What is the all time high annual long term debt for Seelos Therapeutics?
- What is Seelos Therapeutics annual long term debt year-on-year change?
- What is the all time high quarterly long term debt for Seelos Therapeutics?
What is Seelos Therapeutics annual long term debt?
The current annual long term debt of SEEL is $0.00
What is the all time high annual long term debt for Seelos Therapeutics?
Seelos Therapeutics all-time high annual long term debt is $17.89 M
What is Seelos Therapeutics annual long term debt year-on-year change?
Over the past year, SEEL annual long term debt has changed by -$8.20 M (-100.00%)
What is the all time high quarterly long term debt for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly long term debt is $17.89 M